Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation

被引:45
作者
Chesnokova, V [1 ]
Melmed, S [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Los Angeles, CA 90048 USA
关键词
D O I
10.1210/en.141.11.4032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pleiotropic cytokine leukemia inhibitory factor (LIF) is expressed in murine hypothalamus and pituitary and increases POMC gene transcription and ACTH secretion in vitro and in vivo. As hypothalamic pituitary adrenal (HPA) axis activation during inflammation is an important protective mechanism, we determined whether LIF stimulates the HPA inflammatory stress response. Two experimental models were employed: sc injection of complete Freund's adjuvant (CFA) and im administration of turpentine. Hypothalamic LIF gene expression was increased up to 5 days after CFA, and up to 24 h after turpentine. LIF induction was concordant with elevated plasma ACTH and corticosterone levels and pituitary POMC messenger RNA (mRNA) expression. Pituitary levels of LIF-inducible signaling inhibitor (SOCS 3) mRNA were stimulated S-fold after CFA and turpentine treatment. Tn contrast, in LIF knockout mice (LIFKO) pituitary POMC mRNA levels and plasma ACTH and corticosterone responses to both inflammatory challenges were markedly lower than in wild-type (WT) animals. Injection of exogenous LIF (5 mug) to turpentine-treeated LIFKO mice induces POMC gene expression. These results indicate that LIF is an essential component for the neuroendocrine response to inflammatory processes.
引用
收藏
页码:4032 / 4040
页数:9
相关论文
共 45 条
[1]   HUMAN AND MURINE PITUITARY EXPRESSION OF LEUKEMIA INHIBITORY FACTOR - NOVEL INTRAPITUITARY REGULATION OF ADRENOCORTICOTROPIN HORMONE SYNTHESIS AND SECRETION [J].
AKITA, S ;
WEBSTER, J ;
REN, SG ;
TAKINO, H ;
SAID, J ;
ZAND, O ;
MELMED, S .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1288-1298
[2]   Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function - A model for human pituitary Rathke's cysts [J].
Akita, S ;
Readhead, C ;
Stefaneanu, L ;
Fine, J ;
TampanaruSarmesiu, A ;
Kovacs, K ;
Melmed, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2462-2469
[3]   Cytokines: Autocrine and paracrine roles in the anterior pituitary [J].
Arzt, E ;
Stalla, GK .
NEUROIMMUNOMODULATION, 1996, 3 (01) :28-34
[4]   Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter [J].
Auernhammer, CJ ;
Bousquet, C ;
Melmed, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6964-6969
[5]   Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis [J].
Auernhammer, CJ ;
Chesnokova, V ;
Melmed, S .
ENDOCRINOLOGY, 1998, 139 (05) :2201-2208
[6]   Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion [J].
Auernhammer, CJ ;
Chesnokova, V ;
Bousquet, C ;
Melmed, S .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :954-961
[7]   Anti-inflammatory actions of glucocorticoids: molecular mechanisms [J].
Barnes, PJ .
CLINICAL SCIENCE, 1998, 94 (06) :557-572
[8]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[9]   PASSIVE-IMMUNIZATION OF MICE AGAINST D-FACTOR BLOCKS LETHALITY AND CYTOKINE RELEASE DURING ENDOTOXEMIA [J].
BLOCK, MI ;
BERG, M ;
MCNAMARA, MJ ;
NORTON, JA ;
FRAKER, DL ;
ALEXANDER, HR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1085-1090
[10]  
Bousquet C, 1997, J BIOL CHEM, V272, P10551